Global equity issuance rose 43% year over year in the first quarter to $256.8 billion, with initial public offerings up 40% to about $45 billion. After several years in which the new issue market barely functioned, that is a genuine reopening rather than a statistical bounce off a low base.
The more interesting detail is who is listing. The companies coming public this cycle are larger and further along than the historical norm, because a decade of abundant private capital let them postpone the decision. The IPO has stopped being the moment a company raises growth capital and become the moment its early investors get liquidity.
Why the reopening happened now
New issues need two conditions: sellers willing to accept the price and buyers willing to take the risk. Both moved this year. Private equity sponsors have portfolios well past their intended holding periods and limited partners asking for distributions, which turns a merely acceptable price into an acceptable exit. Sponsor-backed listings had their strongest quarter since 2022 late last year.
On the buy side, the demand is anchored by two secular stories. The AI infrastructure buildout has created a supply chain of companies with real revenue and identifiable customers, and defense and space spending has done the same in a different sector. Those are easier to underwrite than the pre-revenue growth stories that defined the last IPO boom.
The breadth is worth noting. Activity now spans real estate, healthcare, metals and mining and consumer retail alongside the two headline themes, which is what a functioning market looks like as opposed to a single crowded trade.
What a more mature issuer changes for a buyer
Whitmore's Watchlist:
IPO (Renaissance IPO ETF): A rules-based basket of recent listings, useful as a read on how the class of 2026 is actually trading.
BX (Blackstone Inc.): A large sponsor whose realizations depend directly on the exit window staying open.
KKR (KKR & Co. Inc.): The same exposure through a different portfolio mix, and a check on whether the pattern is firm-specific.
Buying a company that spent twelve years private is a different proposition from buying one that listed after four. More of the value creation has already happened, and it happened for someone else. The upside available to a public buyer is correspondingly narrower, and the offset is that the business is usually profitable, audited and comprehensible.
That trade is not obviously bad. It is simply different from the one retail investors were trained to expect, and it argues for reading the prospectus for what the proceeds are actually doing. Money raised to fund expansion and money raised to buy out existing holders produce very different subsequent returns.
The financing mix around IPOs says something too. Follow-on offerings and convertible bonds together made up more than a third of last year's equity issuance, which tells you companies already public have been raising capital steadily while the IPO market was shut. The window reopening adds a channel rather than replacing one.
The lockup schedule is the other thing a buyer should know before the first trade. Insiders and pre-IPO holders are typically restricted from selling for months after a listing, and when that restriction lapses the share count available to trade jumps. In a cohort of companies whose whole purpose in listing was to give early investors an exit, that expiry is a more meaningful date than the first day of trading.
The condition that keeps it open
Issuance windows close on volatility, not on valuation. A market that can price risk will absorb an expensive deal; a market that cannot price risk will not absorb a cheap one. That makes this week's Federal Reserve decision more relevant to the IPO calendar than any individual company's numbers.
If the front end reprices sharply in either direction, the deals scheduled for the next few weeks get postponed and the backlog rebuilds. If policy lands roughly where it is priced, the calendar holds. That is the practical reason a reopened window is fragile even when demand is real.
Whitmore's Take: When the average new listing is a mature business selling down its early investors, the case for buying it has to rest on the business rather than on the scarcity of the offering. That is a healthier market and a less exciting one.
Written by Daniel Whitmore
Millionaire Insiders